Cargando…
Prevention and Treatment of Acute Myeloid Leukemia Relapse after Hematopoietic Stem Cell Transplantation: The State of the Art and Future Perspectives
Allogeneic hematopoietic stem cell transplantation (HSCT) for high-risk acute myeloid leukemia (AML) represents the only curative option. Progress has been made in the last two decades in the pre-transplant induction therapies, supportive care, selection of donors and conditioning regimens that allo...
Autores principales: | Leotta, Salvatore, Condorelli, Annalisa, Sciortino, Roberta, Milone, Giulio Antonio, Bellofiore, Claudia, Garibaldi, Bruno, Schininà, Giovanni, Spadaro, Andrea, Cupri, Alessandra, Milone, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745746/ https://www.ncbi.nlm.nih.gov/pubmed/35011994 http://dx.doi.org/10.3390/jcm11010253 |
Ejemplares similares
-
Endothelial Dysfunction after Hematopoietic Stem Cell Transplantation: A Review Based on Physiopathology
por: Milone, Giuseppe, et al.
Publicado: (2022) -
Plerixafor on-demand in association with low-dose cyclophosphamide and G-CSF in the mobilization of patients with multiple myeloma: High effectiveness, low toxicity, and affordable cost
por: Milone, Giuseppe, et al.
Publicado: (2020) -
Handheld Ultrasound or Conventional Ultrasound Devices in Patients Undergoing HCT: A Validation Study
por: Duminuco, Andrea, et al.
Publicado: (2023) -
Venetoclax durable response in adult relapsed/refractory Philadelphia-negative acute lymphoblastic leukemia with JAK/STAT pathway alterations
por: Ferrari, Anna, et al.
Publicado: (2023) -
Preliminary Results of a Combined Score Based on sIL2-Rα and TIM-3 Levels Assayed Early After Hematopoietic Transplantation
por: Leotta, Salvatore, et al.
Publicado: (2020)